Obesity treatment: Australia urged to subsidise GLP-1 drugs amid rising rates

The World Health Organisation (WHO) has urged governments to make GLP-1 medicines such as Ozempic more affordable, publishing new guidelines that endorse the high-profile drugs to treat obesity.
The WHO’s announcement came hours after Austr
Read more...